| Financial Year |
March 31 2023 |
| Monetary Funds |
56,011,155.72 |
| Held-for-trading Financial Assets |
147,261,926.72 |
| Notes Receivable |
78,113,794.39 |
| Accounts Receivable |
143,954,122.41 |
| Advances to Suppliers |
32,968,128.32 |
| Other Receivables |
366,140.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
253,450,604.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,162,225.39 |
| Total Current Assets |
724,534,720.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
229,284,670.58 |
| Under-construction Projects |
240,453,963.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,985,538.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,982,905.20 |
| Deferred Income Tax Assets |
365,216.56 |
| Other Non-Current Assets |
24,967,295.56 |
| Sub-Total of Non-Current Assets |
548,039,590.17 |
| Total Assets |
1,272,574,310.96 |
| Short-Term Loans |
26,231,310.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
54,962,000.00 |
| Accounts Payable |
48,493,672.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,171,931.50 |
| Taxes Payable |
491,218.57 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,234,148.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,100,240.00 |
| Other Current Liabilities |
17,933,113.66 |
| Sub-Total of Current Liabilities |
161,980,923.66 |
| Long-term Loans |
18,914,745.63 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,353,645.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,831,332.23 |
| Total Liabilities |
183,812,255.89 |
| Paid-In Capital(Or Share Stock) |
120,006,000.00 |
| Capital Surplus |
594,359,212.56 |
| Surplus Reserve |
40,601,328.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
333,282,036.18 |
| Minority Stockholder's Interest |
513,478.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,088,248,576.89 |
| Owner's Equity（Stockholder's Equity） |
1,088,762,055.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,272,574,310.96 |
